An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine
/in Breast Cancer, Dendritic Cells, International Publications /von 2010-11-11 / Cancer Immunol. Immunother. 2011 Jan;60(1):87-97Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy
/in Breast Cancer, Hyperthermia, International Publications /von 2010-11-11 / Radiother Oncol 2010 Dec;97(3):535-40Anti-HER2 vaccines: new prospects for breast cancer therapy
/in Breast Cancer, Dendritic Cells, International Publications /von 2010-06-08 / Cancer Immunol. Immunother. 2010 Sep;59(9):1295-312Dendritic cells pulsed with an anti-idiotype antibody mimicking Her-2/neu induced protective antitumor immunity in two lines of Her-2/neu transgenic mice
/in Breast Cancer, Dendritic Cells, International Publications /von 2010-02-24 / Cell. Immunol. 2010;263(1):9-21Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data
/in Breast Cancer, Hyperthermia, International Publications /von 2010-01-01 / Int J Hyperthermia 2010;26(7):612-7Immunizing against breast cancer: a new swing for an old sword
/in Breast Cancer, Dendritic Cells, International Publications /von 2009-10-01 / Breast 2009 Oct;18 Suppl 3:S51-4Tumor vaccines for breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2009-05-01 / Cancer Invest. 2009 May;27(4):361-8Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro
/in Breast Cancer, Dendritic Cells, International Publications /von 2009-01-01 / Cell. Immunol. 2009;257(1-2):23-31Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study
/in Breast Cancer, Dendritic Cells, International Publications, IOZK Veröffentlichungen /von 2008-11-08 / Cancer Immunol. Immunother. 2009 Jun;58(6):887-900
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution